
Reset all filters
01 42care4
02 6Amphastar Pharmaceuticals
03 1Biological E
04 1Cipla
05 1Eli Lilly
06 1Future Health Pharma Gmbh
07 1Lupin Ltd
08 11Novo Nordisk
09 1ORIFARM GROUP AS
10 1Pharmachim Ab
11 4Tetris Pharma
12 1Viatris
13 6Xeris Pharmaceuticals
Reset all filters
01 2Glucagon 1Mg 1 Unit Parenteral Use
02 1INJ
03 5INJECTABLE;INJECTION
04 2Inhalation Powder
05 1Injectable Solution
06 1Nasal Powder In Single-Dose Container
07 3Nasal powder
08 1POWDER
09 1POWDER;NASAL
10 2Powder and liquid to the injection fluid, resolution
11 1SOLUTION;INTRAVENOUS
12 5SOLUTION;SUBCUTANEOUS
13 10Solution For Injection
14 1Vial
15 3Blank
Reset all filters
01 2Allowed
02 7Approved
03 1Authorized
04 2DISCN
05 4Deregistered
06 1Ethical
07 1Originator
08 9RX
09 12Blank
Reset all filters
01 2BAQSIMI
02 6Baqsimi
03 5GLUCAGON
04 2GVOKE HYPOPEN
05 1GVOKE KIT
06 2GVOKE PFS
07 1GVOKE VIALDX
08 3GlucaGen Hypokit
09 1GlucaGen Novo
10 2Glucagen
11 1Glucagen Hypo
12 8Glucagon Novo Nordisk
13 4Ogluo
14 1Blank
Reset all filters
01 3Australia
02 1Canada
03 1India
04 2Italy
05 5Norway
06 1South Africa
07 1Spain
08 11Sweden
09 2Switzerland
10 12USA
Regulatory Info :
Registration Country : Norway
Brand Name : Baqsimi
Dosage Form : Nasal powder
Dosage Strength : mg
Packaging : Endo container 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : GLUCAGON
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/VIAL
Packaging :
Approval Date : 2020-12-28
Application Number : 208086
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BAQSIMI
Dosage Form : POWDER;NASAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2019-07-24
Application Number : 210134
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Baqsimi
Dosage Form : Nasal powder
Dosage Strength : mg
Packaging : Endo container 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Vial
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : GLUCAGON
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/VIAL
Packaging :
Approval Date :
Application Number : 218813
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : GLUCAGON
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1998-09-11
Application Number : 20928
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLUCAGON
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/VIAL
Packaging :
Approval Date : 2025-07-22
Application Number : 214457
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Glucagen Hypo
Dosage Form : Glucagon 1Mg 1 Unit Parenteral Use
Dosage Strength : 1 vial 1 mg + 1 syringe 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Glucagen
Dosage Form : Glucagon 1Mg 1 Unit Parenteral Use
Dosage Strength : 1 vial 1 mg + 1 ampoule solv 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Glucagon Novo Nordisk
Dosage Form : Powder and liquid to the injection fluid, resolution
Dosage Strength : 1 mg
Packaging : Set
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Glucagon Novo Nordisk
Dosage Form : Powder and liquid to the injection fluid, resolution
Dosage Strength : 1 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Baqsimi
Dosage Form : Nasal powder
Dosage Strength : mg
Packaging : Endo container 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : GLUCAGON
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/VIAL
Packaging :
Approval Date : 2024-12-12
Application Number : 204468
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : GVOKE PFS
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.5MG/0.1ML (0.5MG/0.1ML)
Packaging :
Approval Date : 2019-09-10
Application Number : 212097
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GVOKE PFS
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1MG/0.2ML (1MG/0.2ML)
Packaging :
Approval Date : 2019-09-10
Application Number : 212097
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GVOKE HYPOPEN
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.5MG/0.1ML (0.5MG/0.1ML)
Packaging :
Approval Date : 2019-09-10
Application Number : 212097
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GVOKE HYPOPEN
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1MG/0.2ML (1MG/0.2ML)
Packaging :
Approval Date : 2019-09-10
Application Number : 212097
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GVOKE KIT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1MG/0.2ML (1MG/0.2ML)
Packaging :
Approval Date : 2021-08-20
Application Number : 212097
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GVOKE VIALDX
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/0.2ML (1MG/0.2ML)
Packaging :
Approval Date : 2025-03-14
Application Number : 212097
Regulatory Info : RX
Registration Country : USA